Renewal Fuels, Inc. (OTC: RNWF), Operating as American Fusion, Appoints Dr. John E. Brandenburg, Ph.D.

Core Viewpoint - Renewal Fuels, Inc. has appointed Dr. John E. Brandenburg as Chief Technology Officer of Kepler Fusion Technologies, marking a significant step in the company's mission to commercialize the Texatron™ aneutronic fusion platform [1][12][14] Company Overview - Renewal Fuels, Inc. operates under the brand American Fusion following its merger with Kepler Fusion Technologies, focusing on the development and commercialization of fusion energy technologies [14][15] - The company aims to build a scalable, infrastructure-grade fusion energy platform supported by proprietary technology and long-term commercialization objectives [14][15] Appointment of Dr. John E. Brandenburg - Dr. Brandenburg is a senior plasma physicist with over 40 years of experience in fusion energy and applied plasma physics, bringing significant technical expertise to the company [2][12] - His previous roles include senior scientific positions at prestigious institutions such as Lawrence Livermore National Laboratory and Sandia National Laboratories, contributing to national defense and energy initiatives [3][5][12] Dr. Brandenburg's Contributions and Expertise - He has directed various research projects, including the CMTX compact fusion propulsion experiment and has been involved in developing the Texatron™ compact toroidal fusion concept since February 2019 [9][12] - Dr. Brandenburg holds multiple U.S. patents related to plasma reactors and propulsion systems, showcasing his innovative contributions to the field [10][11] Strategic Importance of the Appointment - The CEO of Kepler Fusion Technologies emphasized that Dr. Brandenburg's extensive experience and leadership in developing the Texatron™ platform make him uniquely qualified for the role [12] - His responsibilities will include overseeing technology strategy, reactor physics, experimental validation, and intellectual property development, which are crucial for the company's commercialization readiness [13]